Docetaxel-rechallenge in castration-resistant prostate cancer: defining clinical factors for successful treatment response and improvement in overall survival

Christian Thomas,Maximilian Peter Brandt,Stephanie Baldauf,Igor Tsaur,Sebastian Frees,H. Borgmann,Wolfgang Jäger,Georg Bartsch,Meike Schneider,Robert Dotzauer,Andreas Neisius,Axel Haferkamp

Docetaxel-rechallenge in castration-resistant prostate cancer: defining clinical factors for successful treatment response and improvement in overall survival

2018

Christian Thomas
Maximilian Peter Brandt
Stephanie Baldauf
Igor Tsaur
Sebastian Frees
H. Borgmann
Wolfgang Jäger
Georg Bartsch
Meike Schneider
Robert Dotzauer
Andreas Neisius
Axel Haferkamp

Purpose The purpose of the study was to define clinical factors for successful treatment response and re-exposure to docetaxel in metastatic castration-resistant prostate cancer (mCRPC).

Keywords:

Urology
Prostate cancer
Castration
Docetaxel
Medicine
Diabetes mellitus
overall survival
Nephrology
castration resistant
Internal medicine
treatment response

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations